A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants
Clinical trial NCT06086886 · COMPLETED
Trial details
- NCT number
- NCT06086886
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2024-12-20
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.